{
    "clinical_study": {
        "@rank": "56936", 
        "acronym": "STRATEGY II", 
        "arm_group": [
            {
                "arm_group_label": "One stent technique alone", 
                "arm_group_type": "Experimental", 
                "description": "One stent technique alone for non-true LM bifurcation"
            }, 
            {
                "arm_group_label": "One stent technique + Elective FKB", 
                "arm_group_type": "Experimental", 
                "description": "One stent technique + Elective FKB for non-true LM bifurcation"
            }, 
            {
                "arm_group_label": "Provisional approach", 
                "arm_group_type": "Experimental", 
                "description": "Provisional approach for true LM bifurcation"
            }, 
            {
                "arm_group_label": "Elective 2-stent", 
                "arm_group_type": "Experimental", 
                "description": "Elective 2-stent for true LM bifurcation"
            }
        ], 
        "brief_summary": {
            "textblock": "In patients with unprotected left main (LM) true bifurcation lesion (cohort A), elective\n      2-stent strategy is superior to provisional strategy at preventing the occurrence of\n      12-month target lesion failure after percutaneous coronary intervention for bifurcation\n      lesion.\n\n      In patients with unprotected LM non-true bifurcation lesion (cohort B), 1-stent technique\n      with mandatory final kissing ballooning is superior to 1-stent technique without kissing\n      ballooning at preventing the occurrence of 12-month target lesion failure after percutaneous\n      coronary intervention for bifurcation lesion."
        }, 
        "brief_title": "STRATEGY for Left Main Coronary Bifurcation Lesion II", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age \u226520 years\n\n          2. Left main bifurcation lesion on coronary angiography\n\n          3. Significant myocardial ischemia Main vessel (left main coronary artery and left\n             anterior descending artery) and/or side branch (left circumflex artery) diameter\n             stenosis > 75%, or diameter stenosis 50-75% with angina and/or objective evidence of\n             ischemia in the non-invasive stress test\n\n          4. Significant size of the main branch (left anterior descending artery) and side branch\n             (left cirmflex artery) - The reference diameter of both branches \u2265 2.5 mm by visual\n             estimation\n\n        Exclusion Criteria:\n\n          1. The patient has a known hypersensitivity or contraindication to any of the following\n             medications:  Heparin, Aspirin, Clopidogrel, Biolimus\n\n          2. Patients who have received DES implantation in the target lesion prior to enrollment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "700", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01798433", 
            "org_study_id": "2012-12-039"
        }, 
        "intervention": [
            {
                "arm_group_label": "One stent technique alone", 
                "description": "One stent technique alone with drug-eluting stent", 
                "intervention_name": "One stent technique alone", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "One stent technique + Elective FKB", 
                "description": "One stent technique + Elective FKB with drug-eluting stents + balloon", 
                "intervention_name": "One stent technique + Elective FKB", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Provisional approach", 
                "description": "Provisional approach with drung-eluting stents", 
                "intervention_name": "Provisional approach", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Elective 2-stent", 
                "description": "Elective 2-stent with drug-eluting stents", 
                "intervention_name": "Elective 2-stent", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Angioplasty", 
            "Transluminal", 
            "Percutaneous Coronary"
        ], 
        "lastchanged_date": "December 7, 2013", 
        "location": [
            {
                "contact": {
                    "email": "hcgwon@skku.edu", 
                    "last_name": "Hyoen-Cheol Gwon, MD,PhD", 
                    "phone": "82-2-3410-3418"
                }, 
                "contact_backup": {
                    "email": "youngbin.song@gmail.com", 
                    "last_name": "Young Bin Song, MD", 
                    "phone": "82-2-3410-3419"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "135-710"
                    }, 
                    "name": "Samsung Medical Center"
                }, 
                "investigator": {
                    "last_name": "Hyoen-Cheol Gwon, MD,PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jyhahn@medimail.co.kr", 
                    "last_name": "Joo-Yong Hahn, MD,PhD", 
                    "phone": "82-2-3410-3419"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "135-710"
                    }, 
                    "name": "Samsung Medical Center"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Prospective, Multi-center, Randomized Study to Evaluate the Optimal Strategy for Side Branch Treatment in Patients With Left Main Coronary Bifurcation Lesion", 
        "overall_contact": {
            "email": "hcgwon@skku.edu", 
            "last_name": "Hyeon-Cheol Gwon, MD,PhD", 
            "phone": "82-2-3410-3418"
        }, 
        "overall_contact_backup": {
            "email": "youngbin.song@gmail.com", 
            "last_name": "Young Bin Song, MD", 
            "phone": "82-2-3410-3419"
        }, 
        "overall_official": {
            "affiliation": "Samsung Medical Center", 
            "last_name": "Hyeon-Cheol Gwon, MD,PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "defined ad a composite of cardiac death, spontaneous MI or target lesion revascularization", 
            "measure": "Target lesion failure", 
            "safety_issue": "Yes", 
            "time_frame": "12-month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01798433"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Samsung Medical Center", 
            "investigator_full_name": "Hyeon-Cheol Gwon", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "All deaths were considered cardiac unless a definite non-cardiac cause could be established.", 
                "measure": "Cardiac death", 
                "safety_issue": "Yes", 
                "time_frame": "12-month"
            }, 
            {
                "description": "as measured by 9-month quantitative coronary analysis", 
                "measure": "Angiographic in-segment restenosis rate", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "description": "TVR was defined as repeat revascularization of the target vessel by PCI or bypass graft surgery.", 
                "measure": "Target vessel revascularization (TVR)", 
                "safety_issue": "No", 
                "time_frame": "12-month"
            }, 
            {
                "description": "Stent thrombosis was assessed based on the definitions of the Academic Research Consortium as definite, probable, or possible stent thrombosis.", 
                "measure": "Stent thrombosis", 
                "safety_issue": "Yes", 
                "time_frame": "12-month"
            }, 
            {
                "description": "MI was defined as elevated cardiac enzymes (troponin or MB fraction of creatine kinase, CK-MB) more than the upper limit of the normal value with ischemic symptoms or electrocardiography findings indicative of ischemia that was not related to the index procedure.", 
                "measure": "Myocardial infarction (MI)", 
                "safety_issue": "Yes", 
                "time_frame": "12-month"
            }, 
            {
                "description": "TLR was defined as repeat PCI of the lesion within 5 mm of stent deployment or bypass graft surgery of the target vessel.", 
                "measure": "Target lesion revascularization (TLR)", 
                "safety_issue": "No", 
                "time_frame": "12-month"
            }, 
            {
                "description": "Periprocedural enzyme elevation was defined as a rise in CK-MB \u22653 times the upper normal limit after the index procedure.", 
                "measure": "Periprocedural CK-MB elevation", 
                "safety_issue": "Yes", 
                "time_frame": "the first 48 hours after PCI"
            }, 
            {
                "measure": "Procedure success rate", 
                "safety_issue": "No", 
                "time_frame": "the first 48 hours after PCI"
            }, 
            {
                "measure": "Procedure time", 
                "safety_issue": "No", 
                "time_frame": "immediate after PCI"
            }, 
            {
                "measure": "Amount of contrast dye", 
                "safety_issue": "No", 
                "time_frame": "immediate after PCI"
            }
        ], 
        "source": "Samsung Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Samsung Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}